- Home
- EQC vs BCRX Comparison
EQC vs BCRX Comparison
Compare EQC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQC
- BCRX
- Stock Information
- Founded
- EQC 1986
- BCRX 1986
- Country
- EQC United States
- BCRX United States
- Employees
- EQC N/A
- BCRX N/A
- Industry
- EQC Real Estate Investment Trusts
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQC Real Estate
- BCRX Health Care
- Exchange
- EQC Nasdaq
- BCRX Nasdaq
- Market Cap
- EQC 2.2B
- BCRX 1.9B
- IPO Year
- EQC 1986
- BCRX 1994
- Fundamental
- Price
- EQC $1.74
- BCRX $9.21
- Analyst Decision
- EQC
- BCRX Buy
- Analyst Count
- EQC 0
- BCRX 6
- Target Price
- EQC N/A
- BCRX $15.50
- AVG Volume (30 Days)
- EQC 899.5K
- BCRX 3.0M
- Earning Date
- EQC 02-27-2025
- BCRX 02-24-2025
- Dividend Yield
- EQC N/A
- BCRX N/A
- EPS Growth
- EQC N/A
- BCRX N/A
- EPS
- EQC 0.38
- BCRX N/A
- Revenue
- EQC $58,433,000.00
- BCRX $412,579,000.00
- Revenue This Year
- EQC N/A
- BCRX $38.44
- Revenue Next Year
- EQC N/A
- BCRX $21.23
- P/E Ratio
- EQC $4.52
- BCRX N/A
- Revenue Growth
- EQC N/A
- BCRX 29.92
- 52 Week Low
- EQC $1.40
- BCRX $4.03
- 52 Week High
- EQC $21.00
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- EQC 21.11
- BCRX 65.48
- Support Level
- EQC $1.71
- BCRX $8.63
- Resistance Level
- EQC $1.75
- BCRX $9.00
- Average True Range (ATR)
- EQC 0.04
- BCRX 0.36
- MACD
- EQC 0.17
- BCRX 0.07
- Stochastic Oscillator
- EQC 54.55
- BCRX 85.20
About EQC Equity Commonwealth of Beneficial Interest
Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin, and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.